Literature DB >> 26112057

Effect of menstrual cycle phase on background parenchymal uptake at molecular breast imaging.

Carrie B Hruska1, Amy Lynn Conners2, Celine M Vachon3, Michael K O'Connor2, Lynne T Shuster4, Adam C Bartley3, Deborah J Rhodes4.   

Abstract

RATIONALE AND
OBJECTIVES: The level of Tc-99m sestamibi uptake within normal fibroglandular tissue on molecular breast imaging (MBI), termed background parenchymal uptake (BPU), has been anecdotally observed to fluctuate with menstrual cycle. Our objective was to assess the impact of menstrual cycle phase on BPU appearance.
MATERIALS AND METHODS: Premenopausal volunteers who reported regular menstrual cycles and no exogenous hormone use were recruited to undergo serial MBI examinations during the follicular and luteal phase. A study radiologist, blinded to cycle phase, categorized BPU as photopenic, minimal mild, moderate, or marked. Change in BPU with cycle phase was determined, as well as correlations of BPU with mammographic density and hormone levels.
RESULTS: In 42 analyzable participants, high BPU (moderate or marked) was observed more often in luteal phase compared to follicular (P = .016). BPU did not change with phase in 30 of 42 participants (71%) and increased in the luteal phase compared to follicular in 12 (29%). High BPU was more frequent in dense breasts compared to nondense breasts at both the luteal (58% [15 of 26] vs. 13% [2 of 16], P = .004) and follicular phases (35% [9 of 26] vs. 6% [1 of 16], P = .061). Spearman correlation coefficients did not show any correlation of BPU with hormone levels measured at either cycle phase and suggested a weak correlation between change in BPU and changes in estrone and estradiol between phases.
CONCLUSIONS: We observed variable effects of menstrual cycle on BPU among our cohort of premenopausal women; however, when high BPU was observed, it was most frequently seen during the luteal phase compared to follicular phase and in women with dense breasts compared to nondense breasts.
Copyright © 2015 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Molecular breast imaging; background parenchymal uptake; hormones; menstrual cycle

Mesh:

Substances:

Year:  2015        PMID: 26112057      PMCID: PMC4532620          DOI: 10.1016/j.acra.2015.04.003

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  37 in total

1.  Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy.

Authors:  Amy Lynn Conners; Carrie B Hruska; Cindy L Tortorelli; Robert W Maxwell; Deborah J Rhodes; Judy C Boughey; Wendie A Berg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06       Impact factor: 9.236

2.  Discussion on the alteration of 18F-FDG uptake by the breast according to the menstrual cycle in PET imaging.

Authors:  Hoon-Hee Park; Ji Yun Shin; Ju Young Lee; Gye Hwan Jin; Hyun Soo Kim; Kwang Yul Lyu; Tae Soo Lee
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

3.  Breast-specific gamma imaging for the detection of breast cancer in dense versus nondense breasts.

Authors:  Lauren R Rechtman; Megan J Lenihan; Jennifer H Lieberman; Christine B Teal; Jessica Torrente; Jocelyn A Rapelyea; Rachel F Brem
Journal:  AJR Am J Roentgenol       Date:  2014-02       Impact factor: 3.959

4.  Menstrual cycle-related fluctuations in breast density measured by using three-dimensional MR imaging.

Authors:  Siwa Chan; Min-Ying L Su; Fu-Ju Lei; Jia-Pei Wu; Muqing Lin; Orhan Nalcioglu; Stephen A Feig; Jeon-Hor Chen
Journal:  Radiology       Date:  2011-08-30       Impact factor: 11.105

5.  Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging.

Authors:  Mariko Kajihara; Mariko Goto; Yukari Hirayama; Shoko Okunishi; Setsuko Kaoku; Eiichi Konishi; Nobuhiko Shinkura
Journal:  Magn Reson Med Sci       Date:  2013-03-11       Impact factor: 2.471

6.  The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol.

Authors:  S A Khan; A Sachdeva; S Naim; M M Meguid; W Marx; H Simon; J D Halverson; P J Numann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-10       Impact factor: 4.254

Review 7.  Radiolabeled estradiol derivatives to predict response to hormonal treatment in breast cancer: a review.

Authors:  C Van de Wiele; F De Vos; G Slegers; S Van Belle; R A Dierckx
Journal:  Eur J Nucl Med       Date:  2000-09

8.  Background parenchymal uptake during molecular breast imaging and associated clinical factors.

Authors:  Carrie B Hruska; Deborah J Rhodes; Amy Lynn Conners; Katie N Jones; Rickey E Carter; Ravi K Lingineni; Celine M Vachon
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

9.  Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.

Authors:  Deborah J Rhodes; Carrie B Hruska; Amy Lynn Conners; Cindy L Tortorelli; Robert W Maxwell; Katie N Jones; Alicia Y Toledano; Michael K O'Connor
Journal:  AJR Am J Roentgenol       Date:  2015-02       Impact factor: 3.959

10.  Gamma camera breast imaging lexicon.

Authors:  Amy Lynn Conners; Robert W Maxwell; Cindy L Tortorelli; Carrie B Hruska; Deborah J Rhodes; Judy C Boughey; Wendie A Berg
Journal:  AJR Am J Roentgenol       Date:  2012-12       Impact factor: 3.959

View more
  4 in total

1.  Advances and Future Directions in Molecular Breast Imaging.

Authors:  Matthew F Covington; Ephraim E Parent; Elizabeth H Dibble; Gaiane M Rauch; Amy M Fowler
Journal:  J Nucl Med       Date:  2021-12-09       Impact factor: 11.082

2.  Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study.

Authors:  Carrie B Hruska; Jennifer R Geske; Tiffinee N Swanson; Alyssa N Mammel; David S Lake; Armando Manduca; Amy Lynn Conners; Dana H Whaley; Christopher G Scott; Rickey E Carter; Deborah J Rhodes; Michael K O'Connor; Celine M Vachon
Journal:  Breast Cancer Res       Date:  2018-06-05       Impact factor: 6.466

3.  Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study.

Authors:  Carrie B Hruska; Katie N Hunt; Amy Lynn Conners; Jennifer R Geske; Kathleen R Brandt; Amy C Degnim; Celine M Vachon; Michael K O'Connor; Deborah J Rhodes
Journal:  Breast Cancer Res       Date:  2019-03-08       Impact factor: 6.466

4.  Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study.

Authors:  Carrie B Hruska; Christopher G Scott; Amy Lynn Conners; Dana H Whaley; Deborah J Rhodes; Rickey E Carter; Michael K O'Connor; Katie N Hunt; Kathleen R Brandt; Celine M Vachon
Journal:  Breast Cancer Res       Date:  2016-04-26       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.